| Circulating microRNAs as potential biomarkers for endometriosis SH Cho, L Mutlu, O Grechukhina, HS Taylor Fertility and sterility 103 (5), 1252-1260. e1, 2015 | 178 | 2015 |
| Uterine fibroids: clinical manifestations and contemporary management L Doherty, L Mutlu, D Sinclair, H Taylor Reproductive sciences 21 (9), 1067-1092, 2014 | 128 | 2014 |
| The endometrium as a source of mesenchymal stem cells for regenerative medicine L Mutlu, D Hufnagel, HS Taylor Biology of reproduction 92 (6), 138, 1-11, 2015 | 110 | 2015 |
| Chemoattraction of bone marrow-derived stem cells towards human endometrial stromal cells is mediated by estradiol regulated CXCL12 and CXCR4 expression X Wang, R Mamillapalli, L Mutlu, H Du, HS Taylor Stem cell research 15 (1), 14-22, 2015 | 97 | 2015 |
| HPV types in Turkey: Multicenter hospital based evaluation of 6388 patients in Turkish gynecologic oncology group centers Türkiye'Deki HPV tipleri: Türk jinekolojik onkoloji … P Dursun, A Ayhan, L Mutlu, M Çağlar, A Haberal, T Güngör, M Özat, ... Turk Patoloji Dergisi/Turkish Journal of Pathology 29 (3), 2013 | 83 | 2013 |
| Aromatase inhibitor regulates let-7 expression and let-7f–induced cell migration in endometrial cells from women with endometriosis SH Cho, L Mutlu, Y Zhou, HS Taylor Fertility and sterility 106 (3), 673-680, 2016 | 75 | 2016 |
| Endometrial stem cell transplantation in MPTP‐exposed primates: an alternative cell source for treatment of P arkinson's disease EF Wolff, L Mutlu, EE Massasa, JD Elsworth, D Eugene Redmond Jr, ... Journal of cellular and molecular medicine 19 (1), 249-256, 2015 | 68 | 2015 |
| Micrometastasis of endometriosis to distant organs in a murine model EN Samani, R Mamillapalli, F Li, L Mutlu, D Hufnagel, G Krikun, HS Taylor Oncotarget 10 (23), 2282, 2019 | 46 | 2019 |
| Endometrial cancer in reproductive age: fertility-sparing approach and reproductive outcomes L Mutlu, DD Manavella, G Gullo, B McNamara, AD Santin, P Patrizio Cancers 14 (21), 5187, 2022 | 34 | 2022 |
| Identification of putative fallopian tube stem cells V Snegovskikh, L Mutlu, E Massasa, HS Taylor Reproductive sciences 21 (12), 1460-1464, 2014 | 25 | 2014 |
| Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine diphosphate … JR Tymon-Rosario, P Manara, DD Manavella, S Bellone, TMP Hartwich, ... Gynecologic Oncology 166 (1), 117-125, 2022 | 19 | 2022 |
| Targeted treatment options for the management of metastatic/persistent and recurrent cervical cancer L Mutlu, J Tymon-Rosario, J Harold, G Menderes Expert review of anticancer therapy 22 (6), 633-645, 2022 | 17 | 2022 |
| Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma J Harold, S Bellone, DD Manavella, L Mutlu, B McNamara, TMP Hartwich, ... Gynecologic oncology 168, 157-165, 2023 | 13 | 2023 |
| Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu G Yadav, DM Roque, S Bellone, DD Manavella, TMP Hartwich, M Zipponi, ... Gynecologic Oncology 166 (2), 351-357, 2022 | 13 | 2022 |
| Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate with topoisomerase I inhibitor payload, shows antitumor activity in uterine and ovarian … D Mauricio, S Bellone, L Mutlu, B McNamara, DD Manavella, ... Gynecologic oncology 170, 38-45, 2023 | 12 | 2023 |
| Immune checkpoint inhibitors for recurrent endometrial cancer L Mutlu, J Harold, J Tymon-Rosario, AD Santin Expert Review of Anticancer Therapy 22 (3), 249-258, 2022 | 12 | 2022 |
| Preliminary results of a phase II trial with sacituzumab govitecan-hziy in patients with recurrent endometrial carcinoma overexpressing Trop-2. A Santin, B McNamara, ER Siegel, J Harold, L Mutlu, G Altwerger, ... Journal of Clinical Oncology 41 (16_suppl), 5599-5599, 2023 | 9 | 2023 |
| Pembrolizumab with chemotherapy, with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer B McNamara, Y Chang, L Mutlu, J Harold, AD Santin Expert Opinion on Biological Therapy 23 (3), 227-233, 2023 | 7 | 2023 |
| Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites JY Li, L Mutlu, J Tymon-Rosario, W Khadraoui, N Nagarkatti, P Hui, ... Gynecologic Oncology Reports 39, 100913, 2022 | 6 | 2022 |
| Hyperthermic intraperitoneal chemotherapy in ovarian cancer JH Gelissen, NN Adjei, B McNamara, L Mutlu, JA Harold, M Clark, ... Annals of Surgical Oncology 30 (9), 5597-5609, 2023 | 5 | 2023 |
